Epigenetic Therapy as a Putative Molecular Target to Modulate B Cell Biology and Behavior in the Context of Immunological Disorders

Histone Deacetylase- (HDAC-) dependent epigenetic mechanisms have been widely explored in the last decade in different types of malignancies in preclinical studies. This effort led to the discovery and development of a range of new HDAC inhibitors (iHDAC) with different chemical properties and selec...

Descripción completa

Detalles Bibliográficos
Autores principales: da Costa, Thayse Pinheiro, El-Cheikh, Marcia Cury, Carneiro, Katia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031723/
https://www.ncbi.nlm.nih.gov/pubmed/32090127
http://dx.doi.org/10.1155/2020/1589191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031723/
https://www.ncbi.nlm.nih.gov/pubmed/32090127
http://dx.doi.org/10.1155/2020/1589191

Ejemplares similares